GlassScriptPhysician profile
Andrew Wayne Hurd
NPI 1114217593
$9,981.69
in general payments reported to CMS, 2019-2025
56 companies · $1,978 in 2025
The $1,978 reported for 2025 was more than what 78% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $1,028 · 2021: $1,737 · 2022: $1,509 · 2023: $1,154 · 2024: $1,572 · 2025: $1,978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,703.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,149.05 | 2019-2025 | Fintepla, Briviact |
| Corium, LLC | $1,030.54 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $855.01 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $572.32 | 2019-2025 | Qelbree, Qelbree |
| Sk Life Science, INC. | $539.18 | 2020-2025 | |
| Neurelis, INC. | $528.48 | 2020-2025 | Valtoco |
| Jazz Pharmaceuticals INC. | $481.18 | 2019-2025 | |
| Eisai INC. | $471.45 | 2019-2023 | |
| Livanova USA, INC. | $305.02 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Tris Pharma INC | $279.10 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Greenwich Biosciences, INC. | $275.13 | 2019-2021 | |
| Zogenix INC. | $248.20 | 2020-2021 | |
| Immedica Pharma US, INC. | $235.96 | 2022-2024 | |
| Aquestive Therapeutics, INC. | $233.58 | 2019-2024 | |
| Acadia Pharmaceuticals INC | $179.05 | 2024-2025 | Daybue |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hurd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.